Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Dexmedetomidine and esketamine given around surgery to improve recovery after general anesthesia

Official title: Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery in Patients Undergoing General Anesthesia and Surgery: A 2×2 Factorial Randomized Trial

Run by Peking University First Hospital · NCT07308756 · Data updated 2026-11-12

This trial will test whether giving dexmedetomidine, esketamine, or both during the perioperative period helps adults recover better after surgery under general anesthesia.

More General Anesthesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment316 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedMarch 2027
Study endsApril 2027
Registry record updatedApril 13, 2026
Trial IDNCT07308756 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for at least one-hour surgery under general anesthesia who will receive postoperative patient-controlled intravenous analgesia and can communicate preoperatively.

Probably not a fit

Patients with severe bradycardia or conduction blocks, significant liver or renal failure, intracranial tumors or neurosurgery, certain psychiatric or neurologic disorders, or those not requiring postoperative PCA are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, phase 4, randomized 2x2 factorial trial at Peking University First Hospital assigning adults undergoing general anesthesia to receive dexmedetomidine, esketamine, both, or placebo during the perioperative period. The primary outcome is patient-reported quality of recovery (QoR), a multidimensional measure including pain, sleep quality, cognitive function, and emotional stability, with additional measures such as opioid consumption and adverse events. Eligible participants are adults scheduled for surgeries of at least one hour who will use postoperative patient-controlled intravenous analgesia, while patients with significant cardiac conduction disease, severe organ dysfunction, intracranial disease, or certain neuropsychiatric disorders are excluded. The trial compares the independent and combined effects of the two drugs to see if either or both improve overall postoperative recovery.

Why it matters

Potential benefit: If successful, this could reduce postoperative pain and opioid use, improve sleep and overall recovery, and shorten hospital stays for surgical patients.

How similar studies have gone: Previous studies show perioperative dexmedetomidine or ketamine/esketamine can improve analgesia and sleep, but combining the two and measuring patient-reported quality of recovery is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or over;
* Scheduled to undergo surgery under general anesthesia, with an expected surgical duration of at least 1 hour;
* Required patient-controlled intravenous analgesia after surgery.

Exclusion Criteria:

* Unable to communicate preoperatively due to visual, auditory, or verbal barriers or other reasons;
* Severe bradycardia (heart rate \<50 bpm), sick sinus syndrome, or grade 2 or higher atrioventricular block without pacemaker;
* History of hyperthyroidism or pheochromocytoma;
* History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis, or intracranial hypertension;
* Intracranial tumor or neurosurgery;
* Severe liver dysfunction (Child-Pugh class C), renal failure (requiring renal replacement therapy), or American Society of Anesthesiologists class IV or higher;
* Enrolled in other clinical studies.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.